S. Learned, O. Graff, S. Roychowdhury, R. Moate, K. R. Krishnan, G. Archer, J. G. Modell, R. Alexander, S. Zamuner, A. Lavergne, G. Evoniuk, E. Ratti. Efficacy, safety, and tolerability of a triple reuptake inhibitor GSK372475 in the treatment of patients with major depressive disorder: two randomized, placebo- and active-controlled clinical trials. Journal of Psychopharmacology. 2012, s. 653-662. DOI10.1177/0269881111424931. PMID22048884.
S. Learned, O. Graff, S. Roychowdhury, R. Moate, K. R. Krishnan, G. Archer, J. G. Modell, R. Alexander, S. Zamuner, A. Lavergne, G. Evoniuk, E. Ratti. Efficacy, safety, and tolerability of a triple reuptake inhibitor GSK372475 in the treatment of patients with major depressive disorder: two randomized, placebo- and active-controlled clinical trials. Journal of Psychopharmacology. 2012, s. 653-662. DOI10.1177/0269881111424931. PMID22048884.